Vitrolife AB (publ) Stock Price, News & Analysis (OTCMKTS:VTRLY) $13.30 0.00 (0.00%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$13.30▼$13.3050-Day Range$11.45▼$13.3052-Week Range$11.45▼$21.49VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest About Vitrolife AB (publ) Stock (OTCMKTS:VTRLY)Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; Americas; and Asia. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.Read More VTRLY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VTRLY Stock News HeadlinesOctober 27, 2023 | finance.yahoo.comVitrolife AB (publ) - Interim report Q3, 2023: Profitable growth globally despite headwind in the U.S.October 18, 2023 | wsj.comVitrolife ABDecember 4, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. October 5, 2023 | finance.yahoo.comElection committee for Vitrolife AB (publ)October 4, 2023 | finance.yahoo.comVitrolife Group Annual and Sustainability Report 2022October 4, 2023 | finance.yahoo.comVitrolife: Conference call interim reportOctober 4, 2023 | finance.yahoo.comVitrolife AB: Interim report Q1, 2023: Good start to the yearOctober 4, 2023 | finance.yahoo.comReport from Annual General Meeting of Vitrolife AB (publ)December 4, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. October 4, 2023 | finance.yahoo.comConference call interim report: Vitrolife AB (publ)October 4, 2023 | finance.yahoo.comInterim report Q2, 2023: Strong growth in APAC - Vitrolife AB (publ)October 4, 2023 | finance.yahoo.comVitrolife AB (publ) announces changes in the Board of DirectorsOctober 4, 2023 | finance.yahoo.comMaria Forss, SVP Consumables business area, to leave the Vitrolife GroupOctober 4, 2023 | finance.yahoo.comCEO has purchased shares in Vitrolife ABSee More Headlines Receive VTRLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vitrolife AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:VTRLY CUSIPN/A CIKN/A Webwww.vitrolife.com Phone46-3-17-21-80-00FaxN/AEmployees1,109Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMs. Bronwyn BrophyChief Executive OfficerMr. Patrik Tolf (Age 53)Chief Financial Officer Mr. Claus Bisgaard (Age 46)Senior Vice President of Technologies Mr. Rickard Ericsson (Age 52)Senior Vice President of Global Sales & Marketing Guillermo Ferrando (Age 32)Vice President Strategy & Corporate development Ms. Karin Koritz Russberg (Age 54)Senior Vice President of HR & Sustainability Ricardo Capella (Age 55)Senior Vice President Genetic Services More ExecutivesKey CompetitorsAmbu A/SOTCMKTS:AMBBYBICO Group AB (publ)OTCMKTS:CLLKFCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCCellaVision AB (publ)OTCMKTS:CLVSFView All Competitors VTRLY Stock Analysis - Frequently Asked Questions Should I buy or sell Vitrolife AB (publ) stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vitrolife AB (publ) in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" VTRLY shares. View VTRLY analyst ratings or view top-rated stocks. How have VTRLY shares performed in 2023? Vitrolife AB (publ)'s stock was trading at $11.93 at the beginning of 2023. Since then, VTRLY stock has increased by 11.5% and is now trading at $13.30. View the best growth stocks for 2023 here. How do I buy shares of Vitrolife AB (publ)? Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:VTRLY) was last updated on 12/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vitrolife AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.